跳至主要内容
临床试验/NL-OMON27126
NL-OMON27126尚未招募不适用

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of ALKS 7119 in Healthy Adults

Alkermes, Inc.0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Willing and able to provide informed consent
  • 2. Capable of understanding and complying with the protocol

排除标准

  • 1. Clinically significant medical condition or observed abnormalities, in the opinion of the investigator (including, clinically significant physical examination finding, vital sign result, ECG result, laboratory or urinalysis test result) and/or any other finding that, in the investigator’s judgment, could potentially compromise subject safety, or PK or PD evaluation, or affect the subject’s ability to adhere to the protocol visit schedule, or fulfill visit requirements
  • 2. Female subject that is currently pregnant or breastfeeding, or plans to become pregnant or begin breastfeeding at any point during the study and for 90 days after any study drug administration

研究者

相似试验